| Miramel 0.088 mg tablets PA0126/173/001 |
Pramipexole dihydrochloride monohydrate |
Clonmel Healthcare Ltd |
Marketed |
| Miramel 0.7 mg tablets PA0126/173/003 |
Pramipexole dihydrochloride monohydrate |
Clonmel Healthcare Ltd |
Marketed |
| MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/13-15 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/16-18 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.05 mg prolonged-release tablets EU/1/97/051/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.57 mg prolonged-release tablets EU/1/97/051/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.1 mg prolonged-release tablets EU/1/97/051/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 3.15 mg prolonged-release tablets EU/1/97/051/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Oprymea 2.62 mg prolonged-release tablets EU/1/08/469/046-049 |
Pramipexole dihydrochloride monohydrate |
KRKA, d.d., Novo mesto |
— |
| Oprymea 3.15 mg prolonged-release tablets EU/1/08/469/050-053 |
Pramipexole dihydrochloride monohydrate |
KRKA, d.d., Novo mesto |
— |
| Pramipexole Teva 0.088 mg tablets EU/1/08/490/1-4 |
Pramipexole dihydrochloride monohydrate |
Teva Pharma B.V. |
— |
| Pramipexole Teva 0.18 mg tablets EU/1/08/490/5-8 |
Pramipexole dihydrochloride monohydrate |
Teva Pharma B.V. |
— |
| Pramipexole Teva 0.35 mg tablets EU/1/08/490/9-12 |
Pramipexole dihydrochloride monohydrate |
Teva Pharma B.V. |
— |
| Pramipexole Teva 0.7 mg tablets EU/1/08/490/13-16 |
Pramipexole dihydrochloride monohydrate |
Teva Pharma B.V. |
— |
| SIFROL 0.088 mg tablets EU/1/97/050/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.18 mg tablets EU/1/97/050/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.26 mg prolonged-release tablets EU/1/97/050/013-015 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.35 mg tablets EU/1/97/050/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.52 mg prolonged-release tablets EU/1/97/050/016-018 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.7 mg tablets EU/1/97/050/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.05 mg prolonged-release tablets EU/1/97/050/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.57 mg prolonged-release tablets EU/1/97/050/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.1 mg prolonged-release tablets EU/1/97/050/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.62 mg prolonged-release tablets EU/1/97/050/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 3.15 mg prolonged-release tablets EU/1/97/050/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |